Cargando…

Exploring immunotherapy in colorectal cancer

Chemotherapy combined with or without targeted therapy is the fundamental treatment for metastatic colorectal cancer (mCRC). Due to the adverse effects of chemotherapeutic drugs and the biological characteristics of the tumor cells, it is difficult to make breakthroughs in traditional strategies. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Junyong, Li, Shanbao, Zhu, Zhonglin, Liu, Qi, Zhang, Ruoxin, Yang, Yufei, Li, Xinxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288068/ https://www.ncbi.nlm.nih.gov/pubmed/35842707 http://dx.doi.org/10.1186/s13045-022-01294-4

Ejemplares similares

circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
por: Yang, Yufei, et al.
Publicado: (2022)

Cuproptosis‐related miRNAs signature and immune infiltration characteristics in colorectal cancer
por: Zhu, Zhonglin, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer
por: Zhu, Zhonglin, et al.
Publicado: (2022)

A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer
por: Zhu, Zhonglin, et al.
Publicado: (2022)

Clinical Implications of Nonbiological Factors With Colorectal Cancer Patients Younger Than 45 Years
por: Liu, Qi, et al.
Publicado: (2021)

PROX1 restrains ferroptosis via SCD transcription activation in colorectal cancer: PROX1 inhibits ferroptosis in CRC
por: Zhang, Ruoxin, et al.
Publicado: (2023)

Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients
por: Luo, Dakui, et al.
Publicado: (2023)

PCDHGA9 represses epithelial-mesenchymal transition and metastatic potential in gastric cancer cells by reducing β-catenin transcriptional activity
por: Weng, Junyong, et al.
Publicado: (2020)

RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial–mesenchymal transition and promotes metastasis of colorectal cancer
por: Xiao, Chao, et al.
Publicado: (2019)

Implications of Habitual Alcohol Intake With the Prognostic Significance of Mean Corpuscular Volume in Stage II-III Colorectal Cancer
por: Liu, Qi, et al.
Publicado: (2021)

Challenges and exploration for immunotherapies targeting cold colorectal cancer
por: Li, Dan-Dan, et al.
Publicado: (2023)

Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
por: Li, Shanbao, et al.
Publicado: (2023)

Elevated HOXA13 expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2
por: Qin, Zhiwei, et al.
Publicado: (2019)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression
por: Li, Shanbao, et al.
Publicado: (2020)

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
por: Yu, Xianzhe, et al.
Publicado: (2020)

Clinicopathological Features of Stage I–III Colorectal Cancer Recurrence Over 5 Years After Radical Surgery Without Receiving Neoadjuvant Therapy: Evidence From a Large Sample Study
por: Luo, Dakui, et al.
Publicado: (2021)

Immunotherapy for Colorectal Cancer
por: Boland, Patrick M., et al.
Publicado: (2017)

Immunotherapy, Inflammation and Colorectal Cancer
por: Lichtenstern, Charles Robert, et al.
Publicado: (2020)

N(6)-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction
por: Li, Jinming, et al.
Publicado: (2021)

“Cold” colorectal cancer faces a bottleneck in immunotherapy
por: Liu, Jia-Liang, et al.
Publicado: (2023)

miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2
por: Zhao, Qiuyan, et al.
Publicado: (2018)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

Combinatorial Immunotherapies for Metastatic Colorectal Cancer
por: Janssen, Eline, et al.
Publicado: (2020)

Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy
por: Zheng, Wei, et al.
Publicado: (2022)

An infodemiology study on exploring the quality and reliability of colorectal cancer immunotherapy information
por: Mohamed, Hind, et al.
Publicado: (2023)

The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer
por: Chen, Shiu-Jau, et al.
Publicado: (2021)

Exploring the emerging role of the microbiome in cancer immunotherapy
por: Fessler, Jessica, et al.
Publicado: (2019)

PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer
por: Weng, Junyong, et al.
Publicado: (2018)

Emerging evidence of immunotherapy for colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2022)

Faecal microbial biomarkers in early diagnosis of colorectal cancer
por: Olovo, Chinasa Valerie, et al.
Publicado: (2021)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Emerging phagocytosis checkpoints in cancer immunotherapy
por: Liu, Yu’e, et al.
Publicado: (2023)

Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
por: Wang, Yongchao, et al.
Publicado: (2021)

Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
por: Carlsen, Lindsey, et al.
Publicado: (2022)

NK Cell-Based Immunotherapy in Colorectal Cancer
por: Della Chiesa, Mariella, et al.
Publicado: (2022)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
por: Aldahlawi, Alia M., et al.
Publicado: (2021)

Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
por: Zheng, Yue, et al.
Publicado: (2022)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8qa0qbeld85lfp0qcetl8sgbn2